EKF Diagnostics (LON:EKF) Shares Cross Below 200-Day Moving Average – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 27.22 and traded as low as GBX 26.10. EKF Diagnostics shares last traded at GBX 26.10, with a volume of 244,246 shares trading hands.

EKF Diagnostics Stock Up 2.4%

The firm’s fifty day simple moving average is GBX 25.06 and its 200-day simple moving average is GBX 27.22. The company has a market cap of £113.63 million, a PE ratio of 19.33 and a beta of 0.57. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34.

Insider Transactions at EKF Diagnostics

In related news, insider Julian Baines bought 85,000 shares of EKF Diagnostics stock in a transaction that occurred on Monday, December 15th. The shares were purchased at an average price of GBX 23 per share, with a total value of £19,550. Insiders own 39.62% of the company’s stock.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.